From managing sugar to managing healing

Insulin is a hormone known primarily for regulating sugar levels in the blood, yet researchers at the University of California, Riverside, recently found that applying insulin directly to skin wounds significantly enhanced the healing process.

Skin wounds in rats treated topically with insulin healed faster"surface cells in the epidermis covered the wound more quickly and cells in the dermis, the deeper part of the skin, were faster in rebuilding blood vessels.

In follow-up studies of human skin cells in culture, Manuela Martins-Green and colleagues explored the molecular impact of topical insulin on keratinocytes, the cells that regenerate the epidermis after wounding, and on microvascular endothelial cells, the cells that restore blood flow.

Using various cell and molecular techniques, the researchers discovered that insulin stimulates human keratinocytes in culture to proliferate and migrate. In cultured human microvascular endothelial cells, the insulin stimulates only migration into the wound tissue. The insulin works by switching on cellular signaling proteins called kinases (specifically Src, PI3K, and Akt) and a protein (SREBP) that binds elements in DNA that regulate the production of cholesterol and its relatives.

Chronic or nonhealing wounds take an immense toll on American health and on health care systems. It particularly affects millions of patients with impaired mobility, as well as those with diabetes. Because diabetes is a disease caused by impaired production or utilization of insulin, this work may help explain the connection between diabetes and poor healing.

Says Martins-Green, "This work is important because when we know which cells respond to insulin and which molecules are involved, we may be able to develop ways in which we can make insulin work even better or find ways in which more affordable molecules that mimic these functions of insulin can be developed to treat people who suffer from poor healing."

Source: American Society for Cell Biology

Related stories:

Pure insulin-producing cells produced in mouse
Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs).
New technique eliminates toxic drugs in islet transplant in diabetic mice
The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it.
Two cancer drugs prevent, reverse type 1 diabetes, study shows
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs – imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) – were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.
Why HIV treatment makes people so susceptible to heart disease and diabetes
Clinicians have known for some time that people treated for HIV also become much more susceptible to diabetes and heart disease. A study by scientists at Sydney's Garvan Institute of Medical Research has now shown some of the reasons why – enabling better patient management and monitoring.
Diabetes ABCs 123s
Here is a statistic from the American Diabetes Association that caught my attention: "If current trends continue, one out of three Americans and one in two minorities born in 2000 will develop diabetes in their lifetime."
New biomarker for heart failure identified
Blood levels of resistin, a hormone produced by fat cells, can independently predict an individual's risk of heart failure, cardiologists at Emory University School of Medicine have found.
New advancements in the use of adult, embryonic stem cells for tissue regeneration
A major issue in the development of regenerative medicine is the cell sources used to rebuild damaged tissues. In a review of the issue published in Developmental Dynamics, researchers state that inducing regeneration in humans from the body's own tissues by chemical means is feasible, though many questions must be answered before the process can reach clinical status.
Type-1 diabetes not so much bad genes as good genes behaving badly
Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests.

News discussion:

Medicine & Health news